EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation
Jaclyn S Pearson, Cristina Giogha, Sabrina Muhlen, Ueli Nachbur, Chi LL Pham, Ying Zhang, Joanne M Hildebrand, Clare V Oates, Tania Wong Fok Lung, Danielle Ingle, Laura F Dagley, Aleksandra Bankovacki, Emma J Petrie, Gunnar N Schroeder, Valerie F Crepin, Gad Frankel, Seth L Masters, James Vince, James M Murphy, Margaret Sunde Show all
Nature Microbiology | NATURE PUBLISHING GROUP | Published : 2017
Awarded by Australian National Health and Medical Research Council
Awarded by Australian Research Council
The authors thank E. Mocarski (Emory University) for the gift of Flag-ZBP1/DAI and Flag-M45 and G. Belz (Walter and Eliza Hall Institute) for animal ethics assistance. The authors thank S. Young (Walter and Eliza Hall Institute) for technical assistance. This work was supported by the Australian National Health and Medical Research Council (program grant ID606788 to E.L.H., project grants APP1057888 to J.S., APP1051210 to J.V. and APP1057905 to J.M.M. and J.S., fellowships APP1090108 to J.S.P., APP1052598 to J.V. and APP1105754 to J.M.M.) and the Australian Research Council (Future Fellowship FT130100166 to U.N., Discovery Project DP150104227 to M.S.). C.G. and D.I. were supported by Australian Postgraduate Awards. T.W.F.K. was supported by a University of Melbourne International Research Scholarship (MIRS). G.N.S. is funded by the Medical Research Council, UK. This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS.